How many injections of Roprostim/Romigrastim can increase platelet count?

Romiplostim/Romiplostim is a drug used to treat chronic idiopathic thrombocytopenia (ITP). Since it was approved by the U.S. Food and Drug Administration (FDA) for adult treatment in 2008, its indications have gradually expanded. In 2018, the FDA approved it for use in pediatric patients with an inadequate response to first-line treatment, and further expanded the approval to adult patients with newly diagnosed and persistent ITP who have an inadequate response to first-line treatment or splenectomy.

Roprostim stimulates megakaryocytes in bone marrow and promotes platelet production, thereby effectively increasing platelet count. According to clinical studies, the median duration of platelet response in patients after using loplastin is 11 months, and 32% of patients achieved no treatment response for at least 6 months after receiving this drug. This shows that loplastin can continue to improve patients' platelet levels to a certain extent.

Roplastin is usually administered as a once-weekly subcutaneous injection. During a period of time after injection, the change in platelet count is not immediately apparent. Usually, the platelet count does not increase significantly on the 5th day after injection. However, as treatment progresses, platelet counts generally reach a peak on days 12 to 14 and gradually fall back to baseline by day 28.

Although Ropremilast shows good efficacy in many patients, not all patients respond positively to the drug. Therefore, monitoring and follow-up during treatment are particularly important. The doctor will adjust the medication plan according to the patient's specific situation to ensure the best treatment effect. At the same time, patients also need to be alert to potential side effects when receiving treatment, such as headaches, joint pain, fatigue and other uncomfortable symptoms. These side effects may affect the patient's quality of life, so it is very important to maintain close communication with the doctor during treatment. Timely reporting of any discomfort can help the doctor make necessary assessments and adjustments.